文献速递神经肿瘤脑血管病外科

神经外科创新:不如IDEAL?一项系统综述

Innovation in neurosurgery: less than IDEAL? A systematic review.
PubMed 文献 · Acta Neurochir (Wien) · 2017-08-06

该系统综述评估IDEAL框架用于引入神经外科新技术的可行性,检查了内镜下经鼻入路治疗颅底脑膜瘤(EEMS)和WovenEndobridge(WEB)装置血管内治疗颅内动脉瘤的文献,并按IDEAL框架分类。EEMS纳入26篇论文,无前瞻性研究,无研究报道伦理批准或知情同意,故无临床研究可按IDEAL框架分类;WEB装置筛查6229篇文献纳入21篇,其中2篇为2a期、2篇为2b期。结论认为两种技术均未按IDEAL框架引入,知情同意、伦理批准和严格结局报告等要素可改善神经外科研究质量,替代研究设计和大数据可能是有用的修改。

要点

  • EEMS纳入26篇论文,无前瞻性研究,无研究报道伦理批准或患者知情同意。
  • WEB装置筛查6229篇文献纳入21篇,2篇为2a期、2篇为2b期。
  • 两种技术均未按IDEAL框架引入,框架要素可改善研究质量。

核心结论

  • EEMS和WEB装置均未按照IDEAL框架引入(EEMS病例中该框架为后来开发)。
  • 知情同意、伦理批准和严格结局报告等框架要素重要,可服务于改善神经外科研究质量。
  • 替代研究设计和大数据的使用可能是对神经外科创新IDEAL框架的有用修改。

研究设计与样本

  • 系统综述,评估IDEAL框架用于引入新神经外科手术的可行性。
  • 检查两种创新手术:内镜下经鼻入路治疗颅底脑膜瘤(EEMS)和WovenEndobridge(WEB)装置血管内治疗颅内动脉瘤。
  • 对EEMS和WEB装置的已发表文献进行系统综述,识别的研究按IDEAL框架分期分类。

主要发现

  • 识别576篇描述EEMS的论文,其中26篇被纳入。
  • EEMS无前瞻性研究被识别,无研究报道创新手术的伦理批准或患者知情同意,因此无临床研究可按IDEAL框架分类。
  • WEB装置筛查6229篇文章,其中21篇被纳入。
  • 与EEMS相反,WEB装置有2项研究被分类为2a期、2项为2b期。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical innovation is different from the introduction of novel pharmaceuticals. To help address this, in 2009 the IDEAL Collaboration (Idea, Development, Exploration, Assessment, Long-term follow-up) introduced the five-stage framework for surgical innovation. To evaluate the framework feasibility for novel neurosurgical procedure introduction, two innovative surgical procedures were examined: the endoscopic endonasal approach for skull base meningiomas (EEMS) and the WovenEndobridge (WEB device) for endovascular treatment of intracranial aneurysms. METHODS: The published literature on EEMS and WEB devices was systematically reviewed. Identified studies were classified according to the IDEAL framework stage. Next, studies were evaluated for possible categorization according to the IDEAL framework. RESULTS: Five hundred seventy-six papers describing EEMS were identified of which 26 papers were included. No prospective studies were identified, and no studies reported on ethical approval or patient informed consent for the innovative procedure. Therefore, no clinical studies could be categorized according to the IDEAL Framework. For WEB devices, 6229 articles were screened of which 21 were included. In contrast to EEMS, two studies were categorized as 2a and two as 2b. CONCLUSION: The results of this systematic review demonstrate that both EEMS and WEB devices were not introduced according to the (later developed in the case of EEMS) IDEAL framework. Elements of the framework such as informed consent, ethical approval, and rigorous outcomes reporting are important and could serve to improve the quality of neurosurgical research. Alternative study designs and the use of big data could be useful modifications of the IDEAL framework for innovation in neurosurgery.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Muskens IS, Diederen SJH, Senders JT, et al. Innovation in neurosurgery: less than IDEAL? A systematic review. Acta Neurochir (Wien). 2017. PMID: 28780715. doi:10.1007/s00701-017-3280-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。